Indications for use
Please be aware that our products and their intended and approved usage can vary by territory. We strive to ensure physicians can use our products as they are intended for the benefit of the patient. Take a look at the information below to see the intended use of our Magseed® marker and Magtrace® lymphatic tracer with the Sentimag® probe in your country or territory. If you are a customer, this information is available in your IFU (instructions for use) documentation.
Magseed® marker
Europe
Placement: Any soft tissue.
Implantation: Long-term implantation.
USA
Placement: Any soft tissue.
Implantation: Long-term implantation.
Canada
Placement: Any soft tissue.
Implantation: Long-term implantation.
Hong Kong
Placement: Any soft tissue.
Implantation: Long-term implantation.
Australia + New Zealand
Placement: Any soft tissue.
Implantation: Long-term implantation.
Further note: The sponsors address label is required on the side of the carton.
Magtrace® lymphatic tracer
Europe
Usage: All sentinel lymph node biopsy applications.
Injection: Up to 30 days in advance of use.
USA
Usage: All sentinel lymph node biopsy applications.
Injection: No limit on injection timing. Peritumoral injection indicated, unless used for simple mastectomy.
Canada
Usage: All sentinel lymph node biopsy applications.
Injection: Up to 30 days in advance of surgery.
Hong Kong
Usage: All sentinel lymph node biopsy applications.
Injection: Up to 30 days in advance of use.
Australia + New Zealand
Usage: All sentinel lymph node biopsy applications.
Injection: Up to 30 days in advance of use.